Drug Development

ARS drug development services include: preclinical studies; bioequivalence (BE)/ pharmacokinetics (PK) and therapeutic equivalence (TE) clinical studies for generic drugs; clinical studies for biosimilars and biobetters; Phase I-IV clinical studies for novel pharmaceuticals and biologics.